BIND Therapeutics to Present at JMP Securities Life Sciences Conference 2015

World News: . []

BIND Therapeutics Inc NASDAQ BIND a clinical-stage nanomedicine company developing targeted and programmable therapeutics called AccurinsTM announced today that Andrew Hirsch BINDs president and chief executive office...

More news and information about BIND Therapeutics, Inc.

Published By:

Business Wire: 13:00 GMT Tuesday 16th June 2015

Published: .

Search for other references to "bind" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us